Us Apheresis Equipment Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Apheresis equipment encompasses a range of automated medical devices used to extract specific blood components while returning the remaining elements to the donor or patient. The North American market, encompassing the United States, Canada, and Mexico, holds a dominant global share, driven by advanced healthcare infrastructure and widespread adoption of therapeutic apheresis. The market reached an estimated $3.43 billion in 2025, reflecting sustained demand across blood collection centers, hospitals, and plasma donation facilities.

• •North America commands the largest regional share of the global apheresis equipment market
• •Key end-users include blood banks, hospitals, dialysis centers, and plasma collection facilities
• •Applications span therapeutic apheresis (treating autoimmune and neurological disorders) and donor apheresis (blood component collection)

The market's 7.02% annual growth rate is underpinned by several powerful factors. Increasing prevalence of autoimmune disorders, neurological conditions, and hematological diseases is driving demand for therapeutic apheresis procedures. Additionally, the growing need for plasma-derived medicines, used to treat immunodeficiencies, bleeding disorders, and other conditions, has expanded plasma collection volumes across North America.

• •Rising incidence of autoimmune diseases such as myasthenia gravis and Guillain-Barré syndrome boosts therapeutic apheresis demand
• •Expanding plasma-derived biopharmaceutical industry increases donor apheresis volumes
• •Aging populations and technological improvements in automated apheresis systems broaden clinical applications

The market is segmented by product type, including automated apheresis devices, manual apheresis systems, and disposables such as blood cell separators and tubing sets. North America dominates globally, with the United States accounting for the vast majority of regional revenue due to its well-established healthcare system and high procedure volumes. Canada represents a smaller but growing segment, while Mexico's market is expanding in line with healthcare modernization efforts.

• •Automated apheresis systems represent the largest product segment, driven by efficiency and safety advantages
• •The United States leads North American adoption, supported by extensive blood collection networks and insurance coverage
• •Emerging applications in cellular therapy and regenerative medicine create new growth pockets

What are the recent trends and outlook?

Several trends are shaping the future trajectory of the North American apheresis equipment market. Integration of digital monitoring, wireless connectivity, and data analytics into apheresis systems is enhancing procedural safety and operational efficiency. The growing use of apheresis in emerging therapeutic areas, such as CAR-T cell therapy, stem cell collection, and LDL apheresis for cardiovascular disease, is expanding the addressable market.

• •Digital health integration and real-time patient monitoring are becoming standard features in next-generation apheresis platforms
• •Personalized medicine and cellular therapy applications are creating demand for specialized apheresis configurations
• •Sustainability initiatives are influencing the development of reusable device components and eco-friendly disposables